Viaderma Stock Analysis

VDRM Stock  USD 0.0007  0.0002  40.00%   
Viaderma is overvalued with Real Value of 5.74E-4 and Hype Value of 6.59E-4. The main objective of Viaderma pink sheet analysis is to determine its intrinsic value, which is an estimate of what Viaderma is worth, separate from its market price. There are two main types of Viaderma's stock analysis: fundamental analysis and technical analysis.
The Viaderma pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Viaderma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Viaderma Pink Sheet Analysis Notes

The company has Price to Book (P/B) ratio of 0.0. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Viaderma had not issued any dividends in recent years. The entity had 1:50 split on the 6th of May 2014. ViaDerma, Inc. operates as a specialty pharmaceutical company in the United States. ViaDerma, Inc. was incorporated in 2007 and is headquartered in Marina Del Rey, California. Viaderma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.The quote for Viaderma is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more information please call the company at 310 496 5744 or visit https://viadermalicensing.com.

Viaderma Investment Alerts

Viaderma is way too risky over 90 days horizon
Viaderma has some characteristics of a very speculative penny stock
Viaderma appears to be risky and price may revert if volatility continues
Viaderma has high likelihood to experience some financial distress in the next 2 years
The company has a current ratio of 0.28, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Viaderma until it has trouble settling it off, either with new capital or with free cash flow. So, Viaderma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Viaderma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Viaderma to invest in growth at high rates of return. When we think about Viaderma's use of debt, we should always consider it together with cash and equity.
Viaderma reported the previous year's revenue of 44.69 K. Net Loss for the year was (1.52 M) with profit before overhead, payroll, taxes, and interest of 37.63 K.
Viaderma currently holds about 13.08 K in cash with (167.36 K) of positive cash flow from operations.

Viaderma Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 82.27 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Viaderma's market, we take the total number of its shares issued and multiply it by Viaderma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 22nd of July, Viaderma has the Semi Deviation of 21.84, risk adjusted performance of 0.1192, and Coefficient Of Variation of 852.87. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Viaderma, as well as the relationship between them. Please validate Viaderma variance, as well as the relationship between the value at risk and skewness to decide if Viaderma is priced more or less accurately, providing market reflects its prevalent price of 7.0E-4 per share. As Viaderma appears to be a penny stock we also recommend to double-check its total risk alpha numbers.

Viaderma Price Movement Analysis

The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Simple Moving Average indicator is calculated by adding the closing price of Viaderma for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Viaderma short-term fluctuations and highlight longer-term trends or cycles.

Viaderma Outstanding Bonds

Viaderma issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Viaderma uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Viaderma bonds can be classified according to their maturity, which is the date when Viaderma has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Viaderma Predictive Daily Indicators

Viaderma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Viaderma pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Viaderma Forecast Models

Viaderma's time-series forecasting models are one of many Viaderma's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Viaderma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Viaderma Pink Sheet Analysis

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Viaderma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Viaderma shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Viaderma. By using and applying Viaderma Pink Sheet analysis, traders can create a robust methodology for identifying Viaderma entry and exit points for their positions.
ViaDerma, Inc. operates as a specialty pharmaceutical company in the United States. ViaDerma, Inc. was incorporated in 2007 and is headquartered in Marina Del Rey, California. Viaderma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Viaderma to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Insider Screener Now

   

Insider Screener

Find insiders across different sectors to evaluate their impact on performance
All  Next Launch Module

Other Information on Investing in Viaderma Pink Sheet

Viaderma financial ratios help investors to determine whether Viaderma Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Viaderma with respect to the benefits of owning Viaderma security.